Device
Varnish
Varnish is a medical device with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
100%(1 trials)
Phase Distribution
Ph phase_1
1
33%
Ph not_applicable
2
67%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Recruiting1
Not yet recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 11 (33.3%)
N/A2 (66.7%)
Trials by Status
recruiting133%
not_yet_recruiting133%
completed133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingnot_applicable
Clinical Investigation of the Performance of Epinamel for Dental White Spot Lesions
NCT07730359
not_yet_recruitingnot_applicable
Remineralization Efficacy of Moringa Oleifera Varnish Vs MI Varnish in Initial Carious Lesions Over 6 Months Follow Up: a Randomized Controlled Clinical Trial
NCT06905379
completedphase_1
Safety Evaluation of Advantage Anti-Caries Varnish
NCT02645617
Clinical Trials (3)
Showing 3 of 3 trials
NCT07730359Not Applicable
Clinical Investigation of the Performance of Epinamel for Dental White Spot Lesions
NCT06905379Not Applicable
Remineralization Efficacy of Moringa Oleifera Varnish Vs MI Varnish in Initial Carious Lesions Over 6 Months Follow Up: a Randomized Controlled Clinical Trial
NCT02645617Phase 1
Safety Evaluation of Advantage Anti-Caries Varnish
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3